Radiopharmaceuticals: Technologies and Global Markets

Radiopharmaceuticals: Technologies and Global Markets

Report Code: PHM171A

Publish Date: Sep 2014

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

Report Includes

  • An overview of the global market for radiopharmaceuticals and related technologies.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
  • Details concerning the regulatory environment and the impacts of government on the market.
  • Profiles of leading companies in the industry.

SCOPE OF THE STUDY

The scope of this study encompasses radiopharmaceuticals in pharmaceutical markets. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. The report also covers the brachytherapy seeds. Technological issues include the latest trends and developments. The emerging market for radiopharmaceuticals includes countries like India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Radiopharmaceuticals: Technologies and Global Markets126Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW20Free
Chapter- 4: REGULATORY ASPECTS5Free
Chapter- 5: NEW DEVELOPMENTS4Free
Chapter- 6: MARKET ANALYSIS OF RADIOPHARMACEUTICALS55Free
Chapter- 7: INDUSTRY STRUCTURE FOR BIOPHARMACEUTICALS9Free
Chapter- 8: PATENT ANALYSIS7Free
Chapter- 9: CURRENT SITUATION 3Free
Chapter- 10: C. CRAMER & CO. GMBH16Free
Chapter- 11: ABBREVIATIONS2Free

Related Reports

Antibiotics: Technologies and Global Markets

Published - May 2014 | Publisher - Neha Maliwal | Code - PHM025C

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.

Antibody Drug Conjugates: Technologies and Global Markets

Published - Feb 2014 | Publisher - Kim Lawson | Code - PHM161A

The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%.

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Published - Aug 2013 | Publisher - Shalini Shahani Dewan | Code - PHM043E

The global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012. This market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1%.

Microspheres: Technologies and Global Markets

Published - Jul 2013 | Publisher - Yelena Lipovetskaya | Code - AVM073B

The global market for microspheres was estimated to total nearly $2.2 billion in 2012 and is projected to increase to $2.4 billion in 2013; the market should total $4.4 billion by 2018 and have a five-year compound annual growth rate (CAGR) for of 12.6%.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 58

  • Summary Table: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, THROUGH 2019
  • Table 1: DISCOVERY OF RADIOACTIVITY AND NUCLEAR MEDICINE
  • Table 2: CYCLOTRON RADIONUCLIDE/RADIOISOTOPES
  • Table 3: NUCLEAR REACTOR RADIONUCLIDES/RADIOISOTOPES
  • Table 4: RADIONUCLIDE GENERATORS
  • Table 5: EXAMPLES OF DIAGNOSTIC RADIOPHARMACEUTICALS
  • Table 6: EXAMPLES OF THERAPEUTIC RADIOPHARMACEUTICALS
  • Table 7: EXAMPLES OF ALPHA EMITTERS
  • Table 8: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
  • Table 9: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
  • Table 10: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
Sample Report

Recent Reports

Brain Tumor Therapeutics: Global Markets to 2030

Published - Oct 2025 | Publisher - BCC Publishing | Code - PHM208B

The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.

Global Viral Vector Manufacturing Markets and Technologies Through 2030

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM172B

The global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.

Hyaluronic Acid in Healthcare: Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM284A

The global market for hyaluronic acid medical products is estimated to grow from $8 billion in 2025 to $10.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.

Targeted Alpha Therapies for Cancer Treatment: Global Market

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM287A

This report provides an overview of the global market for targeted alpha therapies for cancer and analyses market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025, forecasted CAGRs through 2030.

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - PHM072B

The global market for rheumatoid arthritis therapies was valued at $28.5 billion in 2024 and is estimated to increase from $30.2 billion in 2025 to reach $41.1 billion by 2030, at a compound annual growth rate (CAGR) of 6.3% from 2025 through 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Radiopharmaceuticals: Technologies and Global Markets
Customize Report
AI: Your Say